Wang J, Xiang M*. Targeting potassium channels Kv1.3 and KC a 3.1: routes to selective immunomodulators in autoimmune disorder treatment? Pharmacotherapy. 2013 May;33(5):515-28. doi: 10.1002/phar.1236.
Release time:2022-11-12
Hits:
- Pre One:Wang J, Cao H, Wang H, Yin G, Du J, Xia F, Lu J, Xiang M*. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice.Toxicol Appl Pharmacol. 2015 Jun 15;285 (3):149-58. doi:1016/j.taap. 2015. 04. 006.
- Next One:Xie S,Feng J,Yu C,Li Z,Wu Y,Cao Z,Li W,He X,Xiang M*,Han S. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilustricostatus.Peptides.2012 Jul;36(1):94-9.